Holdings
31
Concentrated
Top 10 weight
60%
Concentration
Active share
-
Style
Equity
100%
Asset allocation
Portfolio
-Sectors
6High-conviction bets
-Top sector wt.
0.1%Cash
Market-cap allocation
Mid cap65%
Small cap35%
Asset allocation
Equity100%
Top holdings
LAURUS LABS LTDEQUITY
9.4%LUPIN LTDEQUITY
9.3%FORTIS HEALTHCARE LTDEQUITY
7.9%AUROBINDO PHARMA LTDEQUITY
7.0%5.3%
ALKEM LABORATORIES LTDEQUITY
5.2%BIOCON LTDEQUITY
4.7%MANKIND PHARMA LTDEQUITY
4.6%IPCA LABORATORIES LTDEQUITY
3.7%ASTER DM HEALTHCARE LTDEQUITY
3.2%GLAND PHARMA LTDEQUITY
3.2%3.0%
SAI LIFE SCIENCES LTDEQUITY
2.7%WOCKHARDT LTDEQUITY
2.5%NEULAND LABORATORIES LTDEQUITY
2.5%AJANTA PHARMA LTDEQUITY
2.3%NARAYANA HRUDAYALAYA LTDEQUITY
2.2%ABBOTT INDIA LTDEQUITY
2.1%DR. LAL PATH LABS LTDEQUITY
2.0%GRANULES INDIA LTDEQUITY
1.9%GLOBAL HEALTH LTDEQUITY
1.8%PIRAMAL PHARMA LTDEQUITY
1.7%1.6%
1.4%
NATCO PHARMA LTDEQUITY
1.3%1.3%
COHANCE LIFESCIENCES LTDEQUITY
1.2%PFIZER LTDEQUITY
1.1%POLY MEDICURE LTDEQUITY
1.0%F) REPOCASH
0.1%AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- High top-10 concentration (60%).
- Small-cap heavy (35%) - higher volatility.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
77.5%
21.5%
1.0%